Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study The Lancet Regional Health – AmericasPublished: February 9, 2024

https://www.thelancet.com/action/doSearch?dgcid=hubspot_update_feature_updatealerts_lanrhe&text1=COVID-19%20OR%20coronavirus%20OR%20SARS-CoV-2%20OR%202019-nCoV&field1=Title&startPage=&P&utm_campaign=update-lanrhe&utm_medium=email&_hsmi=293160023&_hsenc=p2ANqtz--gWNjuRynUtagqhmGizaYIHWGXsucehVoAwhir76TjQq0_AYiUhR3W92DS0dvGrVyM2MPP_DkIlFBcouBYcniCSoX-Iw&utm_content=293115722&utm_source=hs_email